{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:59:49Z","timestamp":1792807189567,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Deanship of Academic Research, the University of Jordan, Amman, Jordan"},{"name":"The Deanship of Academic Research, the University of Jordan, Amman, Jordan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immune system alteration has been implicated in the pathogenesis of chronic pain conditions, epilepsy and generalized anxiety disorder. Targeting cytokines has recently been proposed for the management of such conditions. Pregabalin (PGB) is an antiepileptic agent used for the management of these conditions. However, little is known about its immunomodulatory effects on cytokine secretion<jats:italic>in vivo<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>. Hence, a mitogen (Lipopolysaccharide [LPS] or Concanavalin A [ConA])-induced murine model of inflammation was used to investigate the effect of PGB on<jats:italic>in vivo<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>IL-1\u03b2, IL-6, TNF-\u03b1 and IL-2 cytokine secretion using ELISA. In addition, PGB effect on spleen histology, as a lymphoid organ, was examined. Our results revealed that PGB significantly inhibited the secretion of ConA-induced IL-6 secretion, basal and ConA-induced TNF-\u03b1 and IL-2 secretion in splenocytes<jats:italic>in vitro<\/jats:italic>.<jats:italic>In vivo<\/jats:italic>, PGB inhibited basal and LPS\/ConA-induced IL-6 and TNF-\u03b1 secretion in addition to LPS-induced IL-1\u03b2 and ConA-induced IL-2 secretion. Moreover, PGB attenuated mitogen-induced inflammatory changes in the spleen. These findings provide an evidence of the anti-inflammatory properties of PGB on cytokine secretion and lymphoid organ inflammation. This might give insights into the role of PGB in the management of the inflammatory state in PGB-indicated conditions.<\/jats:p>","DOI":"10.1038\/s41598-020-61006-1","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:02:30Z","timestamp":1583319750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pregabalin inhibits in vivo and in vitro cytokine secretion and attenuates spleen inflammation in Lipopolysaccharide\/Concanavalin A -induced murine models of inflammation"],"prefix":"10.1038","volume":"10","author":[{"given":"Eman Y.","family":"Abu-rish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad T.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah T.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-7052","authenticated-orcid":false,"given":"Lina A.","family":"Dahabiyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen M.","family":"Aleidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Bustanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"61006_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.anai.2016.09.443","volume":"117","author":"N Godhwani","year":"2016","unstructured":"Godhwani, N. & Bahna, S. L. Antiepilepsy drugs and the immune system. Ann. Allergy Asthma Immunol. 117, 634\u2013640, https:\/\/doi.org\/10.1016\/j.anai.2016.09.443 (2016).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"61006_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","volume":"67","author":"B Blaszczyk","year":"2015","unstructured":"Blaszczyk, B., Lason, W. & Czuczwar, S. J. Antiepileptic drugs and adverse skin reactions: an update. Pharmacol. Rep. 67, 426\u2013434, https:\/\/doi.org\/10.1016\/j.pharep.2014.11.009 (2015).","journal-title":"Pharmacol. Rep."},{"key":"61006_CR3","doi-asserted-by":"publisher","first-page":"806162","DOI":"10.1155\/2014\/806162","volume":"2014","author":"H Himmerich","year":"2014","unstructured":"Himmerich, H. et al. Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro. Oxid. Med. Cell Longev. 2014, 806162, https:\/\/doi.org\/10.1155\/2014\/806162 (2014).","journal-title":"Oxid. Med. Cell Longev."},{"key":"61006_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jpsychires.2013.07.026","volume":"47","author":"H Himmerich","year":"2013","unstructured":"Himmerich, H. et al. Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro. J. Psychiatr. Res. 47, 1751\u20131759, https:\/\/doi.org\/10.1016\/j.jpsychires.2013.07.026 (2013).","journal-title":"J. Psychiatr. Res."},{"key":"61006_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","volume":"29","author":"M Maes","year":"1995","unstructured":"Maes, M., Bosmans, E., Calabrese, J., Smith, R. & Meltzer, H. Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29, 141\u2013152 (1995).","journal-title":"J. Psychiatr. Res."},{"key":"61006_CR6","doi-asserted-by":"publisher","first-page":"e013433","DOI":"10.1136\/bmjopen-2016-013433","volume":"7","author":"KT Houghton","year":"2017","unstructured":"Houghton, K. T. et al. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis. BMJ Open. 7, e013433, https:\/\/doi.org\/10.1136\/bmjopen-2016-013433 (2017).","journal-title":"BMJ Open."},{"key":"61006_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","volume":"159","author":"C Sommer","year":"2018","unstructured":"Sommer, C., Leinders, M. & Uceyler, N. Inflammation in the pathophysiology of neuropathic pain. Pain. 159, 595\u2013602, https:\/\/doi.org\/10.1097\/j.pain.0000000000001122 (2018).","journal-title":"Pain."},{"key":"61006_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.sjpain.2017.08.002","volume":"17","author":"AL Hung","year":"2017","unstructured":"Hung, A. L., Lim, M. & Doshi, T. L. Targeting cytokines for treatment of neuropathic pain. Scand. J. Pain. 17, 287\u2013293, https:\/\/doi.org\/10.1016\/j.sjpain.2017.08.002 (2017).","journal-title":"Scand. J. Pain."},{"key":"61006_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1749-6632.2009.05365.x","volume":"1193","author":"C Iannuccelli","year":"2010","unstructured":"Iannuccelli, C. et al. Pathophysiology of fibromyalgia: a comparison with the tension-type headache, a localized pain syndrome. Ann. N. Y. Acad. Sci. 1193, 78\u201383, https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05365.x (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2018","key":"61006_CR10","doi-asserted-by":"publisher","first-page":"3985154","DOI":"10.1155\/2018\/3985154","volume":"18","author":"M Ernberg","year":"2018","unstructured":"Ernberg, M. et al. Plasma Cytokine Levels in Fibromyalgia and Their Response to 15 Weeks of Progressive Resistance Exercise or Relaxation Therapy. Mediators Inflamm. 18(2018), 3985154, https:\/\/doi.org\/10.1155\/2018\/3985154 (2018).","journal-title":"Mediators Inflamm."},{"key":"61006_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/jpr.S128508","volume":"10","author":"E Backryd","year":"2017","unstructured":"Backryd, E., Tanum, L., Lind, A. L., Larsson, A. & Gordh, T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J. Pain. Res. 10, 515\u2013525, https:\/\/doi.org\/10.2147\/jpr.S128508 (2017).","journal-title":"J. Pain. Res."},{"key":"61006_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.12.008","volume":"316","author":"T Alapirtti","year":"2018","unstructured":"Alapirtti, T. et al. The production of IL-6 in acute epileptic seizure: a video-EEG study. J. Neuroimmunol. 316, 50\u201355, https:\/\/doi.org\/10.1016\/j.jneuroim.2017.12.008 (2018).","journal-title":"J. Neuroimmunol."},{"key":"61006_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neubiorev.2016.02.007","volume":"63","author":"EE De Vries","year":"2016","unstructured":"De Vries, E. E. et al. Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 63, 177\u2013190, https:\/\/doi.org\/10.1016\/j.neubiorev.2016.02.007 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"61006_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-8-29","volume":"8","author":"JT Jarvela","year":"2011","unstructured":"Jarvela, J. T., Lopez-Picon, F. R., Plysjuk, A., Ruohonen, S. & Holopainen, I. E. Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus. J. Neuroinflamm 8, 29, https:\/\/doi.org\/10.1186\/1742-2094-8-29 (2011).","journal-title":"J. Neuroinflamm"},{"key":"61006_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1528-1157.1995.tb01013.x","volume":"36","author":"R Pacifici","year":"1995","unstructured":"Pacifici, R. et al. Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 36, 384\u2013387 (1995).","journal-title":"Epilepsia"},{"key":"61006_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000097189","volume":"1","author":"G De Sarro","year":"1994","unstructured":"De Sarro, G., Rotiroti, D., Audino, M., Gratteri, S. & Nistic\u00f3, G. Effect of interleukin-2 on various models of experimental epilepsy in DBA\/2 mice. Neuroimmunomodulation 1, 361\u2013369, https:\/\/doi.org\/10.1159\/000097189 (1994).","journal-title":"Neuroimmunomodulation"},{"key":"61006_CR17","doi-asserted-by":"publisher","first-page":"e027925","DOI":"10.1136\/bmjopen-2018-027925","volume":"9","author":"H Costello","year":"2019","unstructured":"Costello, H., Gould, R. L., Abrol, E. & Howard, R. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 9, e027925, https:\/\/doi.org\/10.1136\/bmjopen-2018-027925 (2019).","journal-title":"BMJ Open."},{"key":"61006_CR18","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.biopha.2018.09.162","volume":"108","author":"R Aslankoc","year":"2018","unstructured":"Aslankoc, R., Savran, M., Ozmen, O. & Asci, S. Hippocampus and cerebellum damage in sepsis induced by lipopolysaccharide in aged rats - pregabalin can prevent damage. Biomed. Pharmacother. 108, 1384\u20131392, https:\/\/doi.org\/10.1016\/j.biopha.2018.09.162 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"61006_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5152\/eurasianjmed.2018.17261","volume":"50","author":"FS Kilic","year":"2018","unstructured":"Kilic, F. S. et al. Pregabalin attenuates carrageenan-induced acute inflammation in rats by inhibiting proinflammatory cytokine levels. Eurasian J. Med. 50, 156\u2013159, https:\/\/doi.org\/10.5152\/eurasianjmed.2018.17261 (2018).","journal-title":"Eurasian J. Med."},{"key":"61006_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1213\/ANE.0b013e31825d2ad1","volume":"115","author":"Y Jang","year":"2012","unstructured":"Jang, Y., Song, H. K., Yeom, M. Y. & Jeong, D. C. The immunomodulatory effect of pregabalin on spleen cells in neuropathic mice. Anesth. Analg. 115, 830\u2013836, https:\/\/doi.org\/10.1213\/ANE.0b013e31825d2ad1 (2012).","journal-title":"Anesth. Analg."},{"key":"61006_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao, J. et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci. Rep. 9, 5790, https:\/\/doi.org\/10.1038\/s41598-019-42286-8 (2019).","journal-title":"Sci. Rep."},{"key":"61006_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/JAD-180755","volume":"67","author":"SM Barton","year":"2019","unstructured":"Barton, S. M. et al. Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model. J. Alzheimers Dis. 67, 503\u2013513, https:\/\/doi.org\/10.3233\/JAD-180755 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"61006_CR23","doi-asserted-by":"publisher","first-page":"e00348","DOI":"10.1002\/brb3.348","volume":"5","author":"BL Eun","year":"2015","unstructured":"Eun, B. L., Abraham, J., Mlsna, L., Kim, M. J. & Koh, S. Lipopolysaccharide potentiates hyperthermia-induced seizures. Brain Behav. 5, e00348, https:\/\/doi.org\/10.1002\/brb3.348 (2015).","journal-title":"Brain Behav."},{"key":"61006_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2015.11.031","volume":"611","author":"K Sulakhiya","year":"2016","unstructured":"Sulakhiya, K. et al. Lipopolysaccharide induced anxiety- and depressive-like behaviour in mice are prevented by chronic pre-treatment of esculetin. Neurosci. Lett. 611, 106\u201311, https:\/\/doi.org\/10.1016\/j.neulet.2015.11.031 (2016).","journal-title":"Neurosci. Lett."},{"key":"61006_CR25","doi-asserted-by":"publisher","first-page":"271359","DOI":"10.1155\/2013\/271359","volume":"2013","author":"S Biesmans","year":"2013","unstructured":"Biesmans, S. et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm. 2013, 271359, https:\/\/doi.org\/10.1155\/2013\/271359 (2013).","journal-title":"Mediators Inflamm."},{"key":"61006_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1006\/exmp.2000.2322","volume":"69","author":"DR Shanklin","year":"2000","unstructured":"Shanklin, D. R., Stevens, M. V., Hall, M. F. & Smalley, D. L. Environmental immunogens and T-cell- mediated responses in fibromyalgia: evidence for immune dysregulation and determinants of granuloma formation. Exp. Mol. Pathol. 69, 102\u201318 (2000).","journal-title":"Exp. Mol. Pathol."},{"key":"61006_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2478\/acph-2018-0040","volume":"68","author":"SY Elhayek","year":"2018","unstructured":"Elhayek, S. Y., Fararjeh, M. A., Assaf, A. M., Abu-Rish, E. Y. & Bustanji, Y. Immunomodulatory effects of tigecycline in Balb\/c mice. Acta Pharm. 68, 457\u2013469, https:\/\/doi.org\/10.2478\/acph-2018-0040 (2018).","journal-title":"Acta Pharm."},{"key":"61006_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1515\/acph-2017-0035","volume":"67","author":"EY Abu-Rish","year":"2017","unstructured":"Abu-Rish, E. Y., Elhayek, S. Y., Mohamed, Y. S., Hamad, I. & Bustanji, Y. Evaluation of immunomodulatory effects of lamotrigine in BALB\/c mice. Acta Pharm. 67, 543\u2013555, https:\/\/doi.org\/10.1515\/acph-2017-0035 (2017).","journal-title":"Acta Pharm."},{"key":"61006_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.intimp.2007.10.018","volume":"8","author":"M Fararjeh","year":"2008","unstructured":"Fararjeh, M., Mohammad, M. K., Bustanji, Y., Alkhatib, H. & Abdalla, S. Evaluation of immunosuppression induced by metronidazole in Balb\/c mice and human peripheral blood lymphocytes. Int. Immunopharmacol. 8, 341\u2013350, https:\/\/doi.org\/10.1016\/j.intimp.2007.10.018 (2008).","journal-title":"Int. Immunopharmacol."},{"key":"61006_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jneuroim.2018.06.008","volume":"322","author":"EY Abu-rish","year":"2018","unstructured":"Abu-rish, E. Y., Dahabiyeh, L. A., Bustanji, Y., Mohamed, Y. S. & Browning, M. J. Effect of lamotrigine on in vivo and in vitro cytokine secretion in murine model of inflammation. J. Neuroimmunol. 322, 36\u201345, https:\/\/doi.org\/10.1016\/j.jneuroim.2018.06.008 (2018).","journal-title":"J. Neuroimmunol."},{"key":"61006_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.ftd.0000158874.54100.1a","volume":"27","author":"D Berry","year":"2005","unstructured":"Berry, D. & Millington, C. Analysis of pregabalin at therapeutic concentrations in human plasma\/serum by reversed-phase HPLC. Ther. Drug. Monit. 27, 451\u2013456 (2005).","journal-title":"Ther. Drug. Monit."},{"key":"61006_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4314\/tjpr.v15i3.6","volume":"15","author":"EY Abu-rish","year":"2016","unstructured":"Abu-rish, E. Y. et al. Evaluation of antiproliferative activity of some traditional anticancer herbal remedies from Jordan. Trop. J. Pharm. Res. 15, 469\u2013474, https:\/\/doi.org\/10.4314\/tjpr.v15i3.6 (2016).","journal-title":"Trop. J. Pharm. Res."},{"key":"61006_CR33","unstructured":"Bellanti, J. A. Immunology IV: Clinical Applications in Health and Disease (ed. 3) I Care Press, Bethesda (MD), pp 287\u2013363. (2012)."},{"key":"61006_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1289\/ehp.01109s6877","volume":"109","author":"H Tryphonas","year":"2001","unstructured":"Tryphonas, H. Approaches to detecting immunotoxic effects of environmental contaminants in humans. Environ. Health Perspect. 109, 877\u2013884, https:\/\/doi.org\/10.1289\/ehp.01109s6877 (2001).","journal-title":"Environ. Health Perspect."},{"key":"61006_CR35","first-page":"237","volume":"46","author":"JM Dwyer","year":"1981","unstructured":"Dwyer, J. M. & Johnson, C. The use of concanavalin A to study the immunoregulation of human T cells. Clin. Exp. Immunol. 46, 237\u201349 (1981).","journal-title":"Clin. Exp. Immunol."},{"key":"61006_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1615\/CritRevImmunol.v31.i5.20","volume":"31","author":"M Rossol","year":"2011","unstructured":"Rossol, M. et al. LPS-induced cytokine production in human monocytes and macrophages. Crit. Rev. Immunol. 31, 379\u2013446 (2011).","journal-title":"Crit. Rev. Immunol."},{"key":"61006_CR37","doi-asserted-by":"publisher","first-page":"E5665","DOI":"10.1073\/pnas.1604263113","volume":"113","author":"NH Varvel","year":"2016","unstructured":"Varvel, N. H. et al. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc. Natl. Acad. Sci. USA 113, E5665\u20135674, https:\/\/doi.org\/10.1073\/pnas.1604263113 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"61006_CR38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2174\/1871530319666190306095532","volume":"19","author":"Ozlem Ozmen","year":"2019","unstructured":"Ozmen, O. & Topsakal, S. Pregabalin ameliorates lipopolysaccharide-induced pancreatic inflammation in aged rats. Endocr Metab Immune https:\/\/doi.org\/10.2174\/1871530319666190306095532 (2019).","journal-title":"Endocrine, Metabolic & Immune Disorders - Drug Targets"},{"key":"61006_CR39","doi-asserted-by":"publisher","first-page":"e0171147","DOI":"10.1371\/journal.pone.0171147","volume":"12","author":"Y Song","year":"2017","unstructured":"Song, Y. et al. Effect of pregabalin administration upon reperfusion in a rat model of hyperglycemic stroke: Mechanistic insights associated with high-mobility group box 1. PLoS One 12, e0171147, https:\/\/doi.org\/10.1371\/journal.pone.0171147 (2017).","journal-title":"PLoS One"},{"key":"61006_CR40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cyto.2017.10.003","volume":"104","author":"J Khan","year":"2018","unstructured":"Khan, J., Noboru, N., Imamura, Y. & Eliav, E. Effect of Pregabalin and Diclofenac on tactile allodynia, mechanical hyperalgesia and pro inflammatory cytokine levels (IL-6, IL-1\u03b2) induced by chronic constriction injury of the infraorbital nerve in rats. Cytokine 104, 124\u2013129, https:\/\/doi.org\/10.1016\/j.cyto.2017.10.003 (2018).","journal-title":"Cytokine"},{"key":"61006_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.joms.2016.01.022","volume":"74","author":"J Khan","year":"2016","unstructured":"Khan, J., Alghamdi, H., Anwer, M. M., Eliav, E. & Ziccardi, V. Role of Collagen Conduit With Duloxetine and\/or Pregabalin in the Management of Partial Peripheral Nerve Injury. J. Oral. Maxillofac. Surg. 74, 1120\u201330, https:\/\/doi.org\/10.1016\/j.joms.2016.01.022 (2016).","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"61006_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","volume":"95","author":"MC Garcia-Pelayo","year":"2015","unstructured":"Garcia-Pelayo, M. C., Bachy, V. S., Kaveh, D. A. & Hogarth, P. J. BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection. Tuberculosis. 95, 48\u201353, https:\/\/doi.org\/10.1016\/j.tube.2014.10.012 (2015).","journal-title":"Tuberculosis."},{"key":"61006_CR43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.132.2.656","volume":"32","author":"Y Weinstein","year":"1984","unstructured":"Weinstein, Y., Ran, S. & Segal, S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J. Immunol. 32, 656\u201361 (1984).","journal-title":"J. Immunol."},{"key":"61006_CR44","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1189\/jlb.3A1214-601RR","volume":"98","author":"E Kay","year":"2015","unstructured":"Kay, E., Gomez-Garcia, L., Woodfin, A., Scotland, R. S. & Whiteford, J. R. Sexual dimorphisms in leukocyte trafficking in a mouse peritonitis model. J. Leukoc. Biol. 98, 805\u201317, https:\/\/doi.org\/10.1189\/jlb.3A1214-601RR (2015).","journal-title":"J. Leukoc. Biol."},{"key":"61006_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0941-3","volume":"22","author":"D Lam","year":"2017","unstructured":"Lam, D., Lively, S. & Schlichter, L. C. Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K+ channels and migration. J. Neuroinflammation. 22, 166, https:\/\/doi.org\/10.1186\/s12974-017-0941-3 (2017).","journal-title":"J. Neuroinflammation."},{"key":"61006_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cbi.2018.02.022","volume":"284","author":"SB Lee","year":"2018","unstructured":"Lee, S. B. et al. Kaempferol 7-O-\u03b2-D-glucoside isolated from the leaves of cudrania tricuspidata inhibits LPS-induced expression of pro-inflammatory mediators through inactivation of NF-\u03baB, AP-1, and JAK-STAT in RAW 264.7 macrophages. Chem. Biol. Interact. 284, 101\u2013111, https:\/\/doi.org\/10.1016\/j.cbi.2018.02.022 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"61006_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2018.03.058","volume":"202","author":"F Zhao","year":"2018","unstructured":"Zhao, F. et al. Titanium dioxide nanoparticle stimulating pro-inflammatory responses in vitro and in vivo for inhibited cancer metastasis. Life Sci. 202, 44\u201351, https:\/\/doi.org\/10.1016\/j.lfs.2018.03.058 (2018).","journal-title":"Life Sci."},{"key":"61006_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1528-1167.2011.03035.x","volume":"52","author":"E Beghi","year":"2011","unstructured":"Beghi, E. & Shorvon, S. Antiepileptic drugs and the immune system. Epilepsia 52, 40\u20134, https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03035.x (2011).","journal-title":"Epilepsia"},{"key":"61006_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fimmu.2015.00375","volume":"23","author":"B Davenport","year":"2015","unstructured":"Davenport, B., Li, Y., Heizer, J. W., Schmitz, C. & Perraud, A. L. Signature Channels of Excitability no More: L-Type Channels in Immune Cells. Front. Immunol. 23, 375, https:\/\/doi.org\/10.3389\/fimmu.2015.00375 (2015).","journal-title":"Front. Immunol."},{"key":"61006_CR50","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/jnc.12784","volume":"130","author":"CD G\u00f3mez","year":"2014","unstructured":"G\u00f3mez, C. D., Buijs, R. M. & Sitges, M. The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1\u03b2 and TNF-\u03b1 expression in rat hippocampus. J. Neurochem. 130, 770\u2013779, https:\/\/doi.org\/10.1111\/jnc.12784 (2014).","journal-title":"J. Neurochem."},{"issue":"2018","key":"61006_CR51","doi-asserted-by":"publisher","first-page":"8982756","DOI":"10.1155\/2018\/8982756","volume":"16","author":"W Zheng","year":"2018","unstructured":"Zheng, W. et al. Lepidium meyenii Walp Exhibits Anti-Inflammatory Activity against ConA-Induced Acute Hepatitis. Mediators Inflamm. 16(2018), 8982756, https:\/\/doi.org\/10.1155\/2018\/8982756 (2018).","journal-title":"Mediators Inflamm."},{"key":"61006_CR52","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1863","author":"M Rothaug","year":"2016","unstructured":"Rothaug, M., Becker-Pauly, C. & Rose-John, S. The role of interleukin-6 signaling in nervous tissue. Biochim. Biophys. Acta. 1863, 1218\u201327, https:\/\/doi.org\/10.1016\/j.bbamcr.2016.03.018 (2016).","journal-title":"Biochim. Biophys. Acta."},{"key":"61006_CR53","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"38","author":"M Akdis","year":"2016","unstructured":"Akdis, M. et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 38, 984\u20131010, https:\/\/doi.org\/10.1016\/j.jaci.2016.06.033 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"61006_CR54","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/01926230600867743","volume":"34","author":"MF Cesta","year":"2006","unstructured":"Cesta, M. F. Normal structure, function, and histology of the spleen. Toxicol. Pathol. 34, 455\u2013465, https:\/\/doi.org\/10.1080\/01926230600867743 (2006).","journal-title":"Toxicol. Pathol."},{"key":"61006_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/toxsci\/kfs147","volume":"128","author":"KA Criswell","year":"2012","unstructured":"Criswell, K. A. et al. Key components of the mode of action for hemangiosarcoma induction in pregabalin-treated mice: evidence of increased bicarbonate, dysregulated erythropoiesis, macrophage activation, and increased angiogenic growth factors in mice but not in rats. Toxicol. Sci. 128, 22\u201341, https:\/\/doi.org\/10.1093\/toxsci\/kfs147 (2012).","journal-title":"Toxicol. Sci."},{"key":"61006_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jcmm.12991","volume":"21","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Inhibition of cytokine response to TLR stimulation and alleviation of collagen-induced arthritis in mice by Schistosoma japonicum peptide SJMHE1. J. Cell. Mol. Med. 21, 475\u2013486, https:\/\/doi.org\/10.1111\/jcmm.12991 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"61006_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/jf103581r","volume":"59","author":"WC Lin","year":"2011","unstructured":"Lin, W. C. & Lin, J. Y. Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro. J. Agric. Food Chem. 59, 184\u201392, https:\/\/doi.org\/10.1021\/jf103581r (2011).","journal-title":"J. Agric. Food Chem."},{"key":"61006_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/bf02977780.","volume":"30","author":"JY Cho","year":"2007","unstructured":"Cho, J. Y. Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses. Arch. Pharm. Res. 30, 64\u201374, https:\/\/doi.org\/10.1007\/bf02977780. (2007).","journal-title":"Arch. Pharm. Res."},{"key":"61006_CR59","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.10.027","volume":"96","author":"A Vezzani","year":"2015","unstructured":"Vezzani, A. & Viviani, B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacol. 96, 70\u201382, https:\/\/doi.org\/10.1016\/j.neuropharm.2014.10.027 (2015).","journal-title":"Neuropharmacol."},{"key":"61006_CR60","first-page":"43","volume":"11","author":"A Vezzani","year":"2010","unstructured":"Vezzani, A. et al. ICE\/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr. Opin. Investig. Drugs 11, 43\u201350 (2010).","journal-title":"Curr. Opin. Investig. Drugs"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61006-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T02:34:08Z","timestamp":1695868448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61006"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61006-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4007"}}